The filtration frontier: Detoxifying the oceans
Nurse sharks in the Bahamas near Eleuthera Island had traces of drugs like caffeine and painkillers and had impaired metabolism, a new study reports.
Natascha Wosnick
By Susanna Camp
Aquatic life is facing a surge in chemical pollution as drugs, including pharmaceuticals and illicit substances, make their way into marine ecosystems. They’ve been found in concentrations high enough to alter markers of stress and metabolism in local wildlife. Joshua Rapp Learn dives into the details for SN.
🐬 Cocaine sharks
Recent research conducted around a remote island in the Bahamas analyzed aquatic animals’ blood to investigate how illicit drugs persist in seawater and accumulate in marine life (including, yes, cocaine sharks, made famous by a documentary exploring whether illicit activity was exposing animals to drugs). Scientists found that these substances do not merely dilute in the vast ocean; rather, they take a toll on the health of local species, leading to potential ecological shifts.
Our takeaway: the research highlights that modern filtration systems are poorly equipped for these chemical markers, necessitating a move toward better sensors and systems that can detect contaminants at concentrations previously thought to be negligible.
💰 Investing in prevention
Clean water is not just an environmental goal, it’s an economic cornerstone in many communities including the Bahamas. The multitrillion dollar global blue economy relies on healthy coral reefs, sustainable fisheries and safe recreational tourism. Investing in technology that prevents toxins (pharmaceutical, technological or otherwise) from entering our waterways is a pragmatic hedge against the long-term liability costs associated with large-scale environmental remediation and biodiversity loss.
🚽 The filtration frontier
Several companies are currently leading the charge in developing high-performance water quality monitoring and purification solutions:
- Xylem (NYSE: XYL) provides essential smart-monitoring and filtration infrastructure used by municipalities, hospitals and industrial customers to track and remove complex contaminants. The company reported over $9 billion in annual revenue for 2025.
- DuPont Water Solutions (NYSE: DD) manufactures reverse osmosis membranes for large-scale municipal desalination and advanced water purification projects. They dominate the market in the U.S. and are among the top companies worldwide working with cities to filter public drinking water. DuPont maintains a market cap in the range of $19 billion.
- OriginClear has raised over $4 million in funding. Formerly focused on advancing modular, decentralized water-cleaning systems, the company now prioritizes incentivizing private investment in water infrastructure maintenance through the brand Water on Demand.
The ultimate luxury asset may soon be a water supply that hasn’t been chemically modified by someone else’s bad habits.
Disclaimer: The Science News Investors Lab newsletter is for informational purposes only and does not constitute investment advice. Society for Science and Science News Media Group assumes no liability for any financial decisions or losses resulting from the use of the content in this newsletter. Society for Science and Science News Media Group do not receive payments from, and do not have any ownership or investment interest in, the companies mentioned in this newsletter. Please consult a qualified financial advisor before making any investment decisions.